BULLFROG AI HOLDINGS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
BULLFROG AI HOLDINGS, INC. (BFRG) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$1.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-19
- BULLFROG AI HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$1.36M.
- BULLFROG AI HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$1.47M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$1.36M 10-K · filed 2026-03-19 |
| 2024-12-31 | -$1.47M 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |